HIV type 2 epidemic in Spain: challenges and missing opportunities.

作者: Carmen de Mendoza , Teresa Cabezas , Estrella Caballero , Silvia Requena , María J Amengual

DOI: 10.1097/QAD.0000000000001485

关键词:

摘要: : HIV type 2 (HIV-2) is a neglected virus despite estimates of 1-2 million people infected worldwide. HIV-2 less efficiently transmitted than HIV-1 by sex and from mother to child. Although AIDS may develop in carriers, it takes longer HIV-1-infected patients. In contrast with infection, there no global pandemic caused HIV-2, as the largely confined West Africa. extent due socioeconomic ties wars, prevalent Portugal its former colonies Brazil, India, Mozambique Angola. Globally, infections are steadily declining over time. A total 338 cases infection had been reported at Spanish registry until December 2016, whom 63% were men. Overall 72% sub-Saharan Africans, whereas 16% native Spaniards. Dual coinfection was found 9% Heterosexual contact most likely route acquisition more 90% cases. Roughly one-third presented CD4 cell counts 200 cells/μl and/or clinical events. Plasma RNA undetectable baseline 40% To date, carriers have received antiretroviral therapy, using integrase inhibitors 32 individuals. New diagnoses Spain remained stable since 2010 an average 15 yearly. Illegal immigration Northwestern African borders accounts for 75% new diagnoses. Given relatively large community Africans already living continuous flux endemic regions, either alone or should be excluded once all HIV-seroreactive persons, especially when showing atypical serological profiles, immunovirological disconnect (CD4 count loss viremia) high epidemiological risks (birth partners regions).

参考文章(82)
Nuno Taveira, Pedro Borrego, HIV-2 susceptibility to entry inhibitors. Aids Reviews. ,vol. 15, pp. 49- 61 ,(2013)
Saraswathi Nk, Babu Pg, Devapriya F, John Tj, The detection of HIV-2 infection in southern India. Indian Journal of Medical Research. ,vol. 97, pp. 49- 52 ,(1993)
David Nicolás, Juan Ambrosioni, Roger Paredes, M Ángeles Marcos, Christian Manzardo, Asunción Moreno, José M Miró, None, Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4. Expert Review of Anti-infective Therapy. ,vol. 13, pp. 947- 963 ,(2015) , 10.1586/14787210.2015.1056157
Helen R. Fryer, Carla Van Tienen, Maarten Schim Van Der Loeff, Peter Aaby, Zacarias J. Da Silva, Hilton Whittle, Sarah L. Rowland-Jones, Thushan I. de Silva, Predicting the extinction of HIV-2 in rural Guinea-Bissau AIDS. ,vol. 29, pp. 2479- 2486 ,(2015) , 10.1097/QAD.0000000000000844
Akum Aveika Awasana, Ramu Sarge-Njie, Koya Ariyoshi, Steve Kaye, Diarmuid O'Donovan, Abraham Alabi, Maarten F Schim van der Loeff, Hilton C Whittle, Paul Milligan, Andreas Hansmann, Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV-2-infected women in a community-based cohort in The Gambia. Journal of Acquired Immune Deficiency Syndromes. ,vol. 38, pp. 335- 341 ,(2005)
Benoit Visseaux, Charlotte Charpentier, Gilles Collin, Mélanie Bertine, Gilles Peytavin, Florence Damond, Sophie Matheron, Eric Lefebvre, Françoise Brun-Vézinet, Diane Descamps, ANRS CO5 HIV-2 Cohort, None, Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates PLOS ONE. ,vol. 10, pp. e0134904- ,(2015) , 10.1371/JOURNAL.PONE.0134904
Ricardo Jorge Camacho, Special Aspects of the Treatment of HIV-2-Infected Patients Intervirology. ,vol. 55, pp. 179- 183 ,(2012) , 10.1159/000332025
Sophie Matheron, Sophie Pueyo, Florence Damond, François Simon, Annie Leprêtre, Pauline Campa, Roger Salamon, Genevieve Chêne, Françoise Brun-Vezinet, French HIV-2 Cohort Study Group, Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort. AIDS. ,vol. 17, pp. 2593- 2601 ,(2003) , 10.1097/00002030-200312050-00006
Kristen Andreatta, Michael D Miller, Kirsten L White, None, HIV-2 antiviral potency and selection of drug resistance mutations by the integrase strand transfer inhibitor elvitegravir and NRTIs emtricitabine and tenofovir in vitro. Journal of Acquired Immune Deficiency Syndromes. ,vol. 62, pp. 367- 374 ,(2013) , 10.1097/QAI.0B013E31827B55F1
Gustavo Cilla, Berta Rodés, Emilio Pérez-Trallero, Julio Arrizabalaga, Vincent Soriano, Molecular evidence of homosexual transmission of HIV type 2 in Spain. AIDS Research and Human Retroviruses. ,vol. 17, pp. 417- 422 ,(2001) , 10.1089/088922201750102481